tiprankstipranks
pc:medip

MEDIPOST Inc

MEDIPOST Inc. is a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven and degenerative diseases. The company advances a pipeline of regenerative medicine built on a proprietary stem cell technology platform with a focus on scalable, off-the-shelf therapeutic approaches.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$140M
Total Amount Raised$140M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$140M
Latest Funding Amount$140M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 09, 2026
Investment
$140.00M

Investors

Investor Name
Funding Round

Related News and Analysis